Reported 4 days ago
Bankrupt genetic testing company 23andMe has received judicial approval to attempt the sale of its valuable customer medical and ancestry data, raising privacy and safety worries amid its financial struggles. The process is set with tight deadlines, prompting fears from customers about how their sensitive information will be handled. A call for a third-party privacy ombudsman has emerged, with bankruptcy officials emphasizing the need to protect consumer data throughout the sale.
Source: YAHOO